Clinical article by David Ludvigson
Newly awarded patent entitled "Nanoelectronic Electrochemical Test Device" strengthens protection for Nanōmix's eLab® System.
The patent provides protection for Nanōmix's unique approach to mobile, point-of-care diagnostic testing.
The Nanōmix rapid POC tests utilize an innovative platform incorporating highly sensitive, low cost carbon nanostructure biosensors that can be used for a wide range of assays and sample types.
Read more ▶